financetom
Business
financetom
/
Business
/
Vertex Pharmaceuticals Insider Sold Shares Worth $32,292,320, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vertex Pharmaceuticals Insider Sold Shares Worth $32,292,320, According to a Recent SEC Filing
Nov 17, 2025 1:45 PM

04:20 PM EST, 11/17/2025 (MT Newswires) -- Jeffrey M Leiden, Director, Executive Chairman, on November 13, 2025, sold 73,292 shares in Vertex Pharmaceuticals ( VRTX ) for $32,292,320. Following the Form 4 filing with the SEC, Leiden has control over a total of 24,466 common shares of the company, with 24,026 shares held directly and 440 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532025000234/xslF345X05/wk-form4_1763413922.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aethlon Medical Enrolls First Patient in Hemopurifier Trial -- Shares Up 14% Pre-Bell
Aethlon Medical Enrolls First Patient in Hemopurifier Trial -- Shares Up 14% Pre-Bell
Nov 11, 2024
08:41 AM EST, 11/11/2024 (MT Newswires) -- Aethlon Medical ( AEMD ) said Monday that the first patient has been enrolled in an Australian clinical trial of its immunotherapeutic device Hemopurifier to treat patients with solid tumors. The company said the trial will treat patients who have stable or progressive disease while receiving anti-PD-1 monotherapy, such as Keytruda or Opdivo....
Pinterest Engagement Improvements Driving Growth, Wedbush Says
Pinterest Engagement Improvements Driving Growth, Wedbush Says
Nov 11, 2024
08:37 AM EST, 11/11/2024 (MT Newswires) -- Pinterest ( PINS ) is executing well against its user engagement and monetization strategies and appears set to show growth and profits in line with its guidance, Wedbush said in a note on Monday. Reaction to the company's Q3 results is overdone, Wedbush said, and out of line with the company's compound annual...
Dell Technologies' AI Momentum Building 'Even Faster' as New Opportunities Arise, Morgan Stanley Says
Dell Technologies' AI Momentum Building 'Even Faster' as New Opportunities Arise, Morgan Stanley Says
Nov 11, 2024
08:45 AM EST, 11/11/2024 (MT Newswires) -- Dell Technologies' ( DELL ) artificial intelligence infrastructure momentum is building even faster as more than $20 billion of AI server revenue is anticipated for the company in fiscal 2026, Morgan Stanley said in a Monday note. Morgan Stanley expects the company to ship 48,000 8-GPU AI server equivalents in fiscal 2026, representing...
Dynavax Technologies to Repurchase $100 Million From Goldman Sachs
Dynavax Technologies to Repurchase $100 Million From Goldman Sachs
Nov 11, 2024
08:43 AM EST, 11/11/2024 (MT Newswires) -- Dynavax Technologies ( DVAX ) said Monday it signed a deal with Goldman Sachs ( GS ) to repurchase $100 million of shares under an accelerated share repurchase transaction, or ASR. The transaction is part of Dynavax's ( DVAX ) $200 million share repurchase program launched this month, the company said. After the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved